RT @EUPatient: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://t…
5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://t.co/dFr2PO0HYq
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
Retweeted European Urology (@EUplatinum): Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://t.co/IsgLUS57DU #ProstateCancer https://t.co/GM3QsWEYgG
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://t.co/PaL6annhKQ #ProstateCancer https://t.co/4eh4wtuPK3
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
RT @EUplatinum: 5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://…
5-year distant metastasis is the most robust predictor of survival for men receiving radiation after prostatectomy https://t.co/4D0ZaScoct #pcsm #prostatecancer
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
RT @EUplatinum: Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://…
Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival https://t.co/I5HYrAoxPK @DrSpratticus #prostatecancer
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival. - PubMed - NCBI https://t.co/v5XDtb9av8
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
Intermediate endpoints are sorely needed in the oncology space. I really like the statistical framework utilized by the authors. Nicely done! @DrSpratticus @wandering_gu https://t.co/Ej5EAvzpQm
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
Another trial showing distant mets free survival as surrogate to OS in locally prostate cancer https://t.co/m2poUWQCXC
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
RT @PCF_Science: #PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #…
#PCFfunded study: 5-Yr Distant Metastasis is intermediate clinical endpoint (ICE) best associated w/ overall survival in #ProstateCancer patients receiving post-prostatectomy radiation therapy. In line w/ PCF-ICECAP findings on MFS as robust ICE for OS.